Anthrax Treatment Market Trends

Growth Drivers

• Rising Burden of Zoonotic Disorders – Bacillus anthracis, a gram-positive rod, is the source of the zoonotic infection anthrax, which are facultative anaerobic microbes that produce toxins and are encapsulated. According to the World Health Organization (WHO), zoonoses account for around 60% of newly discovered infectious illnesses that are documented worldwide.
• Growing Rate of Biological Attacks- One of the most likely agents to be employed in a biological strike is the bacteria that produces anthrax, Bacillus anthracis which has been employed in biowarfare and bioterrorism since 1914, and a tiny quantity is all that is needed to infect a big number of individuals.
• Increasing Agriculture Industry- Nearly every continent has seen reports of anthrax, and agricultural areas with neutral or alkaline, calcareous soils are the most typical locations for the disease which is acknowledged on a global scale as a significant public health and economic issue. For instance, globally, the agriculture industry is expected to expand by over 5% between 2024 and 2028, reaching a market size of around USD 4 trillion by that year.
• Surging Prevalence of Rare Diseases- In the industrialized world, anthrax is quite uncommon; it is more prevalent in Africa and central and southern Asia resulting from breathing in bacillus anthracis spores.

Challenges

• Lack of Awareness - One of the key elements contributing to the illness outbreaks is cattle owners' ignorance of anthrax which has resulted from inadequate surveillance, monitoring, and disease reporting; lack of public knowledge; unfettered mobility; inefficient management; and vaccine regimens. An inadequate understanding of anthrax and how it spreads is a major contributing factor in human cases which might result from contact with contaminated raw meat or blood and the slaughter of sick animals.
• Moreover, the recurrence of anthrax outbreaks in various parts of the world calls for increased awareness since it is imperative to remain vigilant to avoid, identify, and contain outbreaks.
• Complexity of diagnosis may increase the need for specialized laboratory tests causing delays in the treatment
• Exorbitant cost of treatment is expected to limit its accessibility in lower-economic regions.